IBMS Congress 2025

Does the WHO standard address diagnostic uncertainty in semen analysis?

9am – 9.30am BST, 23 September 2025 ‐ 30 mins

Cytopathology

Post vasectomy semen analysis: Is it time for a change?

9.30am – 10am BST, 23 September 2025 ‐ 30 mins

Cytopathology

Learning outcomes

By the end of the presentation the delegates should:

• Have knowledge of the current guidelines
• Be aware of the evidence for change
• Be aware of how PVSA could change

Evaluating sperm quality: Scientific insights and key considerations for male reproductive health

10.30am – 11am BST, 23 September 2025 ‐ 30 mins

Cytopathology

Abstract

This presentation will cover:

• Biological factors
• key metrics
• lifestyle and environmental impact
• sperm assessment techniques
• fertility implications
• emerging research
• improvement strategies
• ethical considerations

Psychosexual, psychosocial and psychosomatic aspects of infertility

11am – 11.30am BST, 23 September 2025 ‐ 30 mins

Cytopathology

Abstract

This presentation will discuss:

The impact of infertility on couples, particularly the male partner.

Reproductive renaissance: Andrology training and reflection of one year on the HSST

11.30am – 12pm BST, 23 September 2025 ‐ 30 mins

Cytopathology

Abstract

This presentation will cover:

The pathways for training and development to include the specialist, ARCS and how these can support development.

HSST review following Year 1 of training as a Consultant Scientist

Lymphoma histology for Cytologists

9am – 9.30am BST, 24 September 2025 ‐ 30 mins

Cytopathology

Abstract

• Normal Lymph node structures using histology images
• Diagnosing Lymphoma on histology - morphology and ancillary testing
• Typing and sub-typing of lymphoma - is it important?

Lymphoma Cytology – how far can we go?

9.30am – 10am BST, 24 September 2025 ‐ 30 mins

Cytopathology

Learning outcomes

Delegates will gain knowledge on:

• The role of cytology in the diagnosis of lymphoma
• The limitations of cytology in the diagnosis of lymphoma
• Flow Cytometry on cytology samples
• Cytology and histology correlations

Reporting systems – serous fluid and urine cytology

10.30am – 11am BST, 24 September 2025 ‐ 30 mins

Cytopathology

Abstract

This presentation will cover:

• Overview of the recommended reporting systems
• The importance of standardised communications with clinical teams and the impact to patients
• Application of the reporting systems based on morphological assessments and ancillary testing

WHO reporting systems – pancreatic and respiratory cytology

11am – 11.30am BST, 24 September 2025 ‐ 30 mins

Cytopathology

Abstract

This presentation will cover:

• An overview of the recommended reporting systems
• The importance of standardised communications with clinical teams and the impact to patients
• Application of the reporting systems based on morphological assessments and ancillary testing

Comparison of roles and responsibilities of biomedical scientists in the UK compared with rest of Europe

11.30am – 12pm BST, 24 September 2025 ‐ 30 mins

Cytopathology

Abstract

• An overview of the unique opportunities available in the UK for BMS roles and the frameworks that have enabled this.
• Promotion of expanded roles and IBMS/RCPath qualifications
• Insight into the roles of cytotechnologists in Europe, common challenges, restrictions and the implications it has on individuals and cytology service provisions.

Speakers

Professor Allan Wilson

Consultant Biomedical Scientist, IBMS Past President, NHS Lanarkshire

Find out more

Changing landscape of cervical cytology and diagnostic cytopathology (molecular/digital/AI)

2pm – 3pm BST, 24 September 2025 ‐ 1 hour

Cytopathology

Learning outcomes

Delegates attending this presentation will be able to:

• Explain the fundamental concepts of digital pathology and artificial intelligence, including their roles and applications in modern cytology.
• Summarise recent advancements in cervical cytology, focusing on techniques, technologies, and methodologies that enhance screening and diagnosis.
• Analyse the latest innovations in diagnostic cytology, including improvements in accuracy, efficiency, and the integration of molecular techniques.
• Discuss strategies for integrating digital pathology and AI into clinical practice, emphasising the importance of adaptability and continuous learning in the evolving landscape of pathology.
• Understand how advancements in cytology and pathology can lead to improved patient outcomes.

Changes in treatment due to molecular testing (gynae and diagnostic cytology)

3pm – 3.30pm BST, 24 September 2025 ‐ 30 mins

Cytopathology

Abstract

This presentation will cover:

• Application and relevance of molecular testing in Gynae and Diagnostic cytology
• How it is applied to patient pathways
• Implications to patients

Indeterminate thyroid lesions

4pm – 4.30pm BST, 24 September 2025 ‐ 30 mins

Cytopathology

Absract

This presentation will cover:

• Overview of the Thy reporting systems
• New RCPath guidance
• Challenges with reporting indeterminate lesions
• Clinical limitations of Thy3a and Thy3f lesions
• What an indeterminate diagnosis means to the clinician and the patient

Idylla™ ThyroidPrint® study – UK multi-centre validation

4.30pm – 5pm BST, 24 September 2025 ‐ 30 mins

Cytopathology

Abstract

This presentation will discuss:

• The current limitations of cytology on indeterminate THY3 thyroid lesions
• Molecular risk stratification and the benefits to patient
• The ThyroidPrint® test
• The study results3

Speakers

Leonie Wheeldon

Consultant Biomedical Scientist - Diagnostic Cytopathology, Royal Cornwall Hospitals NHS Trust

Find out more

Digital cervical cytology: The Monklands experience

9.30am – 10am BST, 25 September 2025 ‐ 30 mins

Cytopathology

Learning outcomes

The Scottish exclusion audit

9.30am – 10am BST, 25 September 2025 ‐ 30 mins

Cytopathology

Speakers

Professor Allan Wilson

Consultant Biomedical Scientist, IBMS Past President, NHS Lanarkshire

Find out more

Results of BAC survey - Impact of centralisation of services

10.30am – 10.50am BST, 25 September 2025 ‐ 20 mins

Cytopathology

Validating the Hologic Genius system for the NHSCSP

10.50am – 11.10am BST, 25 September 2025 ‐ 20 mins

Cytopathology

Hologic Genius system – a service evaluation

11.10am – 11.30am BST, 25 September 2025 ‐ 20 mins

Cytopathology

Global Digital Cytology

11.30am – 12pm BST, 25 September 2025 ‐ 30 mins

Cytopathology

Speakers

Professor Allan Wilson

Consultant Biomedical Scientist, IBMS Past President, NHS Lanarkshire

Find out more

Interesting and difficult cases – cervical cytology

2pm – 2.30pm BST, 25 September 2025 ‐ 30 mins

Cytopathology

Abstract

Presentation and discussion of case studies from interesting and/or difficult cases in cervical cytology.

Speakers

Monika Bhardwaj

Consultant Biomedical Scientist, The Royal Wolverhampton NHS Trust

Find out more

Glandular lesions – impact of false negatives

2.30pm – 3pm BST, 25 September 2025 ‐ 30 mins

Cytopathology

Learning outcomes

Delegates will understand:

• Impact of false negatives
• Pitfalls
• Medici legal implications

A Canterbury Tale: Cervical screening scandals and litigation

3pm – 3.30pm BST, 25 September 2025 ‐ 30 mins

Cytopathology

Abstract

This presentation will discuss:

• Internal quality control and trend analysis
• Patient harm and impact of high profile cases
• Media and political  responses to screening problems
• Litigation